Drug for treating vital myocarditis

A technology of viral myocarditis and drugs, applied in antiviral agents, drug combinations, pharmaceutical formulas, etc., can solve the problems of no good treatment, poor efficacy of arrhythmia, unsatisfactory treatment effect of myocarditis, etc., and achieve low recurrence rate , ideal treatment effect, symptom improvement effect

Inactive Publication Date: 2013-05-29
CHENGDU JIANJIANG PHARMA FACTORY
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the therapeutic effect of Western medicine on myocarditis is not satisfactory.
For patients with viral myocarditis, there are few effective antiviral drugs in Western medicine, which affects the treatment of myocarditis
Also less effective against arrhythmias in patients with chronic myocarditis
Especially the cardiomyopathy developed from myocarditis, the etiology is still unknown, and there is no good treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] The present embodiment is the method for preparing pills.

[0017] Take 10 parts of Radix Isatidis, 8 parts of Daqing Ye, 2 parts of Ginseng, 6 parts of Salvia, 8 parts of Astragalus, 2 parts of Honeysuckle, 2 parts of Panax notoginseng, 3 parts of Fushen, 5 parts of Baiziren, 5 parts of Asparagus, and 4 parts of Leech , 2 parts of Chuanxiong, 5 parts of Schisandra, 3 parts of licorice, and 3 parts of Polygala. Steam in boiling water at 100°C for 60 minutes, spread to cool and then dry in the sun, crush the above raw materials into fine powder and mix evenly, add cinnamon aldehyde, creatinine, vitamin C and coenzyme Q10, etc. Water is mixed and stirred, and cinnabar is used as a coating to make pills.

Embodiment 2

[0019] This embodiment is a method for preparing an aqueous solution.

[0020] Take 15 parts of Radix Isatidis, 12 parts of Daqing Ye, 6 parts of Ginseng, 10 parts of Salvia, 12 parts of Astragalus, 3 parts of Honeysuckle, 4 parts of Panax notoginseng, 6 parts of Fushen, 13 parts of Baiziren, 13 parts of Asparagus, and 8 parts of leeches , 4 parts of Chuanxiong, 13 parts of Schisandra, 12 parts of licorice, 6 parts of polygala, and 2 parts of cinnabar.

[0021] Add water that is 5 times the weight of the medicinal materials used and boil it. After boiling on a high fire, change it to a slow fire and boil it for 20 minutes, filter it out, and repeat three times. Mix the three water preparations, add cinnamon aldehyde, creatinine, vitamin C, coenzyme Q10 and honey as appropriate, divide into several parts, and take according to the dosage of ordinary Chinese medicine.

Embodiment 3

[0023] This embodiment is a method for preparing tablets.

[0024] Take 8 parts of Radix Isatidis, 10 parts of Daqing Ye, 4 parts of Ginseng, 8 parts of Salvia, 10 parts of Astragalus, 2 parts of Honeysuckle, 3 parts of Panax notoginseng, 4 parts of Fushen, 7 parts of Baiziren, 10 parts of Asparagus, and 7 parts of leech , 3 parts of Chuanxiong, 10 parts of Schisandra, 10 parts of licorice, 5 parts of polygala, and 1 part of cinnabar. Steam in boiling water at 100°C for 60 minutes, spread to cool and then dry in the sun. Grind the above raw materials into fine powder and mix evenly. Add cinnamon aldehyde, creatinine, vitamin C and coenzyme Q10 as appropriate. Mix evenly and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug for treating vital myocarditis, and the drug is prepared from the following raw materials in parts by weight: 10-15 parts of radix isatidis, 8-12 parts of folium isatidis, 2-6 parts of ginseng, 6-10 parts of radix salviae miltiorrhizae, 8-12 parts of radix astragali, 2-3 parts of honeysuckle flowers, 2-4 parts of pseudo-ginseng, 3-6 parts of poria with hostwood, 5-13 parts of platycladi seeds, 5-13 parts of radix asparagi, 4-8 parts of leeches, 2-4 parts of rhizoma ligustici wallichii, 5-13 parts of fructus schizandrae, 3-12 parts of liquorice, 3-6 parts of polygala tenuifolia and 1-2 parts of cinnabar and also contains cinnamaldehyde, creatinine, a vitamin C, coenzyme Q10, and the like. The drug disclosed by the invention combines the traditional and Western medicine, can be used for treating both symptoms and root causes, has the effects of diminishing inflammation and resisting viruses, tonifying Qi and replenishing blood, nourishing yin and clearing heat, nourishing heart and calming nerves, eliminating evil and strengthening healthy energy and can be used for treating palpitation, short breath, heart meridian disorder, chest distress, asthenia, spontaneous perspiration, limb and mind fatigue, precordial pain, severe palpitation and intermittent pulse. After the drug disclosed by the invention is taken by a patient, an ideal treatment effect is achieved, and the myocarditis symptoms are obviously improved or eliminated.

Description

technical field [0001] The invention relates to a medicine for treating heart diseases, in particular to a medicine for treating viral myocarditis. Background technique [0002] In recent years, the relative incidence of viral myocarditis has been increasing. The severity of the disease is different, and the manifestations are very different. Infants and young children are more serious, and adults are more mild. Mild cases may have no obvious symptoms, and severe cases may be complicated by severe arrhythmia. Heart failure or even sudden death. [0003] Myocarditis refers to localized or diffuse acute, subacute or chronic inflammatory lesions in the myocardium. Generally speaking, myocarditis is viral myocarditis caused by viral infection. Viral myocarditis is myocardial inflammation caused by viruses. Its basic symptoms are precordial discomfort, dull pain, palpitation, shortness of breath, chest tightness, fatigue and easy tiredness, muscle aches all over the body, and a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8965A61P9/00A61P31/12A61K33/28A61K35/62
Inventor 张强
Owner CHENGDU JIANJIANG PHARMA FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap